•
Zhejiang-based BrainAurora Medical Technology Limited (HKG: 6681), the first company in China to combine neuroscience and artificial intelligence (AI) technology for developing medical-grade digital therapy products, has successfully completed an initial public offering (IPO) of 181,112,000 shares on the Hong Kong Stock Exchange. The offering, priced at HKD 3.22 per…
•
China-based Internet healthcare solutions provider Fangzhou Inc. (HKG: 6086) has entered into a partnership with the China unit of US major Bristol-Myers Squibb (BMS, NYSE: BMY). The collaboration, with financial details undisclosed, aims to jointly develop a digital medicine platform and upgrade the Internet health management model, marking a significant…
•
Germany-based Bayer AG (ETR: BAYN) has announced plans to acquire HiDoc Technologies GmbH in the first quarter of 2025, marking a significant step in the company’s expansion into digital health solutions. Alongside this acquisition, Bayer is initiating the commercialization of its digital health application, Cara Care, which is designed to…
•
The Hainan Medical Products Administration has granted marketing approval to a heart-lung walking test data analysis software following a priority review process. This digital therapy product, classified as a Category II medical device, is designed to assist healthcare professionals in evaluating patients’ exercise cardiopulmonary function, excluding automatic diagnosis. The approval…
•
HAIKOU—The People’s Government of Hainan Province has unveiled the “Hainan Province’s Three Year Action Plan for High Quality Development of Digital Health System and Digital Health Economy (2024-2026),” setting its sights on establishing a comprehensive, industry-leading digital health ecosystem. The plan envisions a vibrant innovation landscape that benefits the public,…
•
Shanghai Ark Biopharmaceutical Co., Ltd (ArkBio), a Chinese biopharmaceutical company, has entered into a partnership with SDODT, a domestic innovator in digital therapeutics technology. The collaboration aims to enhance the marketing and commercialization efforts for products targeting Attention Deficit Hyperactivity Disorder (ADHD) treatment. ADHD is a prevalent chronic neurodevelopmental disorder…
•
UK-based AstraZeneca (AZ; NASDAQ: AZN) has launched Evinova, a digital health solutions provider, with the aim of supporting global clinical development. Evinova offers AI-enabled technologies and services to clinical trial (CT) sponsors, clinical research organizations (CROs), CT site care teams, and patients. The new business unit will initially focus on…
•
Germany-headquartered Bayer (ETR: BAYN) has announced a strategic partnership with US digital developer Mahana Therapeutics. The collaboration focuses on the distribution and marketing of Mahana’s digital technologies, further expanding Bayer’s foray into the digital health sector. This move follows Bayer’s launch earlier this year of a precision health product development…
•
Medidata, a wholly owned subsidiary of France firm Dassault Systèmes (EPA: DSY), has announced a strategic partnership with the East Clinical Center of Oncology (ECCO) and GoBroad Healthcare Group. The collaboration aims to explore the digital transformation of cancer clinical trials and enhance the clinical application of Rave EDC (Electronic…
•
China-based rare disease specialist Sperogenix Therapeutics Limited has entered into a partnership with compatriot firm LUCA Healthcare Limited Co., a company specializing in digital targeting and healthcare solutions, to bolster the application of digital therapy in myasthenia gravis. The collaboration aims to enhance the use of digital therapy in treating…
•
AffaMed Digital, a company wholly owned by AffaMed Technologies—a joint venture between AffaMed Therapeutics and SIFI S.p.A.—has announced the first patient enrollment in a clinical study for its AMD201 at the Beijing Tiantan Hospital. This marks a significant step in the development of digital therapies for post-stroke cognitive impairment (PSCI).…
•
UK-based Smith & Nephew Plc has announced a strategic partnership with China’s Shanghai Fudong Medical Management Co., Ltd, also known as MedMotion, a leading digital health company. This collaboration aims to enhance digitalization innovation and explore comprehensive “pre-operative, intraoperative, and post-operative” perioperative management solutions. Aim to Revolutionize Post-Operative RehabilitationThe partnership…
•
US-based Abbott (NYSE: ABT) has entered into a strategic partnership with Sinopharm’s China National Medical Device Co., Ltd. The collaboration aims to leverage the respective strengths of both companies in technology, service network, and other areas to enhance the distribution of advanced medical technologies and solutions in China. Partnership Scope…
•
We-Linking, a developer of fully implantable wireless brain-computer interface systems based in Shenzhen, has reportedly secured “tens of millions” of renminbi in an angel financing round. The funding round was led by Bluerun Ventures and CDH Investments, with participation from Naton Technology and Guokr.com. Company Background and AchievementsFounded in 2019,…
•
ThinmedTech, a chronic disease clinical management solution provider based in Chongqing, has struck a partnership with West China Hospital. The collaboration aims to work together on medical research and product transformation in the area of “chronic kidney disease (CKD) sodium restriction digital therapy.” This partnership marks a significant step in…
•
Med Vision, a Hangzhou-based digital therapy specialist, has reportedly raised “tens of millions” of renminbi in a Series A+ financing round. The funding was led by Hangzhou Lingxin Enterprise Management Partnership, with a contribution from existing investor Med-Fine Capital. The proceeds will be used to accelerate the commercialization of multiple…
•
Nans Tech, a brain dysfunction digital therapy developer based in Hangzhou, reportedly raised “tens of million” of renminbi in a Series A financing round, solely led by Shulan Junjie Capital. Proceeds will go towards product industrialization and regulatory filing, technology and product research and development, and clinical promotion. Company Background…
•
China-based digital health solutions provider Luca Healthcare has announced a strategic partnership and license agreement with UK firm Cambridge Cognition. Under the agreement, Luca has secured a 10-year exclusive license to commercialize Cambridge Cognition’s suite of cognitive assessment tools in mainland China. Financial details of the agreement were not disclosed.…
•
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda Pharmaceutical Co., Ltd (TYO: 4502) and US firms Amazon Web Services (AWS) and Accenture. The collaboration also marks the initiation of “TakedaSpark+”, an innovation incubation platform launched by the Japan-based firm in 2021. Through this…
•
Shanghai-based digital cognitive impairment solution provider Best Covered reportedly raised RMB 100 million (USD 14.2 million) in a Series A+ financing round. The round was led by Cenova Ventures, with additional participation from Long Hill Capital, GSR Ventures, and BioTrack Capital. The proceeds will be used for scientific research investment,…